Peanut is a common childhood allergen in the United States (US). According to recent estimates approximately 1.4-4.5% of children suffer from peanut allergy. It is more common in males (1.7% versus 0.8%), people with lower income (1.7% versus 1.2%), and there are race/ethnic disparities in the prevalence of peanut allergies (2.8% non-Hispanic blacks, 1.7% Hispanics, and 0.9% non-Hispanic whites). In addition, peanut allergy is the leading cause of death from anaphylaxis due to food, particularly in teenagers, though the rate is low. The national food allergy death registry reports fewer than four deaths per year over the past 10 years in the US.
Treatments of Interest:
- peanut immunotherapy (Viaskin® Peanut, DBV Technologies)
- peanut immunotherapy (PalforziaTM, Aiummune)
Below you will find the final documents from the assessment review process: